Lars Hanan, Co-Founder and Partner at BroadOak Capital Partners, invests in growth-stage life sciences companies. See sector focus and contact routes.
Lars Hanan, Co-Founder and Partner at BroadOak Capital Partners, invests in **growth-stage** life sciences companies, specifically targeting sectors like **life sciences tools, diagnostics, biopharma services**, and emerging fields such as **cell and gene therapy** and **single-cell genomics**[2][8][11]. His firm provides **growth capital and advisory services** to underserved life sciences companies, with notable portfolio investments including **Empire Genomics**, **Azenta Life Sciences**, and **PBS Biotech**[2][7]. Hanan’s distinctive thesis emphasizes **data-driven strategies** and a thematic focus on **innovation** to identify growth opportunities in life sciences tools and services that traditional financial providers often overlook[2].
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Bethesda.
Investors like Lars Hanan · Full investor directory · Investor access · Company funding database